Yasmeen Shamsi | Hypertension | Best Researcher Award

Posted on by Pencis

Yasmeen Shamsi | Hypertension | Best Researcher Award

Prof Yasmeen Shamsi, Jamia Hamdard, India

Yasmeen Shamsi is a prominent researcher in the field of hypertension. She has made significant contributions to our understanding of high blood pressure and its management, which has earned her accolades and recognition in the scientific community. Her research often focuses on the mechanisms underlying hypertension, innovative treatment approaches, and the impact of lifestyle factors on blood pressure regulation.

Profile:
Scopus Profile 
Education:

Yasmeen Shamsi earned her Bachelor of Unani Medicine and Surgery (BUMS) degree from Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, in 1987. She further pursued advanced studies at Jamia Hamdard in New Delhi, where she completed her Doctor of Medicine (MD) in Moalajat, a branch of Unani medicine, in 2003.

Teaching  Experience:

Dr. Yasmeen Shamsi has a distinguished career in medical education, with significant contributions as a clinical educator and researcher. From 1995 to 2001, she served as a Clinical Registrar at Majeedia Hospital, providing valuable clinical demonstrations to interns and students. She taught Tashreeh-wo-Munafaul Aza (Anatomy & Physiology) to B.U.M.S. first-year students at Jamia Hamdard from July to December 1999. Following this, Dr. Shamsi taught Ummor-e-Tabiya to first-year B.U.M.S. students at Jamia Hamdard from October 2001 to December 2012. Since January 2013, she has been instructing B.U.M.S. second-year students in Ilmul Amraz and B.U.M.S. third-year students, as well as MD (Moalajat) students in Moalajat, continuing her impactful teaching at Jamia Hamdard.

 

Research Experience:

Dr. Yasmeen Shamsi has dedicated over 22 years to clinical research, focusing on a wide array of topics. As a Principal Investigator, she led several significant research projects at HNF, New Delhi. From 2000 to 2002, she examined the effects of Dam-Tab on blood glucose levels in Type-II diabetes mellitus patients and assessed the clinical efficacy of Marham Muhasa in treating acne vulgaris. Her research continued from 2001 to 2005, evaluating the pharmacological effects of Lipotab on lipoprotein levels, and a placebo-controlled, double-blind randomized trial of Qurs-e-Mafasil in rheumatoid arthritis. Between 2003 and 2006, she investigated the impact of Hairi oil and Hairi Plus oil on hair loss. Her subsequent projects, from 2006 to 2009, included a clinical study of Dawa-e-Musakkin for generalized anxiety disorder and an evaluation of Hamdoroid Capsule & Hamdoroid Ointment for hemorrhoids. She also studied the efficacy of a herbal formulation, ‘Diabeat,’ as an adjunct for controlling Type-2 diabetes mellitus from 2007 to 2011.

In her role as a Co-Investigator from 1995 to 1998 at HNF, New Delhi, Dr. Shamsi contributed to studies on Pitkirya Capsules for urticaria treatment, Entropher Tablets for irritable bowel syndrome, and the effectiveness of Qurs Supari Pak Jadeed and Unishaf Pessary for leucorrhoea associated with cervicitis and cervical erosion. Additionally, she co-investigated the clinical trial of Jigreen Syrup and Jigreen Tablet against viral hepatitis.

Top Notable Publications:

  • “Hijāmah (Cupping Therapy) for Pain Management in Patients with Cervical Spondylosis”
    Khan, R., Shamsi, Y., Khan, S.A., Nikhat, S., & Akhtar, W.
    Alternative Therapies in Health and Medicine, 2023, 29(7), pp. 268–271.

  • “Clinical Evaluation of a Topical Unani Pharmacopoeial Formulation Tila-e-Kalf in the Management of Melasma (Kalf): A Randomized Controlled Clinical Trial”
    Salma, Shamsi, Y., Nikhat, S., Akhtar, Md.W., & Ahmad, S.
    Avicenna Journal of Phytomedicine, 2023, 13(3), pp. 255–264.
  • “A Polyherbal Formulation Habb-e-Ustukhuddus Induces Apoptosis and Inhibits Cell Migration in Lung and Breast Cancer Cells without Any Toxicity in Mice”
    Punia, R., Ali, M., Shamsi, Y., & Singh, R.P.
    Asian Pacific Journal of Cancer Prevention, 2023, 24(8), pp. 2713–2727.
  • “Role of AMP-Activated Protein Kinase on Cardio-Metabolic Abnormalities in the Development of Diabetic Cardiomyopathy: A Molecular Landscape”
    Haye, A., Ansari, M.A., Rahman, S.O., Ahmed, D., & Sharma, M.
    European Journal of Pharmacology, 2020, 888, 173376.
  • “Cichorium intybus Attenuates Streptozotocin Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Inflammatory Response in Rats”
    Sharma, M., Afaque, A., Dwivedi, S., Khan, M.I., Ahmed, D.
    Interdisciplinary Toxicology, 2019, 12(3), pp. 111–119.
  • “Clinically Significant Improvement in a Case of Bronchial Asthma with Unani Medicine: A Case Report”
    Shamsi, Y., Khan, R., & Nikhat, S.
    Traditional and Integrative Medicine, 2019, 4(4), pp. 130–136.

  • “Siris (Albizzia lebbeck (L.) Benth.) in View of Unani and Contemporary Pharmacology”
    Khan, S., Shamsi, Y., & Jahangir, U.
    International Journal of Green Pharmacy, 2018, 12(2), pp. S306–S314.